Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 2001;9(3):149–154. doi: 10.1155/S1064744901000278

Female Genital Warts: Global Trends and Treatments

Stanley A Gall 1,✉
PMCID: PMC1784648  PMID: 11516064

Abstract

The increasing incidence of human papillomavirus (HPV) infection and HPV-associated conditions such as genital warts in women is a global concern. Genital warts are a clinical manifestation of HPV types 6 and 11, and are estimated to affect 1% of sexually active adults aged between 15 and 49. HPV infection is also strongly associated with cervical cancer, and is prevalent in as many as 99% of cases. The psychological stress of having genital warts is often greater than the morbidity of the disease, and therefore successful treatment is crucial. Current treatments are patient-applied and provider-administered therapies. Imiquimod 5% cream, a patient-applied therapy, is an efficacious treatment with tolerable side-effects and a low recurrence rate, and has the potential to be an effective strategy for the management of genital warts.

Full Text

The Full Text of this article is available as a PDF (289.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baer H., Allen S., Braun L. Knowledge of human papillomavirus infection among young adult men and women: implications for health education and research. J Community Health. 2000 Feb;25(1):67–78. doi: 10.1023/a:1005192902137. [DOI] [PubMed] [Google Scholar]
  2. Beutner K. R., Ferenczy A. Therapeutic approaches to genital warts. Am J Med. 1997 May 5;102(5A):28–37. doi: 10.1016/s0002-9343(97)00181-2. [DOI] [PubMed] [Google Scholar]
  3. Beutner K. R., Wiley D. J., Douglas J. M., Tyring S. K., Fife K., Trofatter K., Stone K. M. Genital warts and their treatment. Clin Infect Dis. 1999 Jan;28 (Suppl 1):S37–S56. doi: 10.1086/514722. [DOI] [PubMed] [Google Scholar]
  4. Cates W., Jr Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis. 1999 Apr;26(4 Suppl):S2–S7. doi: 10.1097/00007435-199904001-00002. [DOI] [PubMed] [Google Scholar]
  5. Cheah P. L., Looi L. M. Biology and pathological associations of the human papillomaviruses: a review. Malays J Pathol. 1998 Jun;20(1):1–10. [PubMed] [Google Scholar]
  6. Chuang T. Y., Perry H. O., Kurland L. T., Ilstrup D. M. Condyloma acuminatum in Rochester, Minn, 1950-1978. II. Anaplasias and unfavorable outcomes. Arch Dermatol. 1984 Apr;120(4):476–483. [PubMed] [Google Scholar]
  7. Coleman N., Birley H. D., Renton A. M., Hanna N. F., Ryait B. K., Byrne M., Taylor-Robinson D., Stanley M. A. Immunological events in regressing genital warts. Am J Clin Pathol. 1994 Dec;102(6):768–774. doi: 10.1093/ajcp/102.6.768. [DOI] [PubMed] [Google Scholar]
  8. Edwards L., Ferenczy A., Eron L., Baker D., Owens M. L., Fox T. L., Hougham A. J., Schmitt K. A. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol. 1998 Jan;134(1):25–30. doi: 10.1001/archderm.134.1.25. [DOI] [PubMed] [Google Scholar]
  9. Feldman J. G., Chirgwin K., Dehovitz J. A., Minkoff H. The association of smoking and risk of condyloma acuminatum in women. Obstet Gynecol. 1997 Mar;89(3):346–350. doi: 10.1016/S0029-7844(97)00011-2. [DOI] [PubMed] [Google Scholar]
  10. Filiberti A., Tamburini M., Stefanon B., Merola M., Bandieramonte G., Ventafridda V., De Palo G. Psychological aspects of genital human papillomavirus infection: a preliminary report. J Psychosom Obstet Gynaecol. 1993 Jun;14(2):145–152. doi: 10.3109/01674829309084437. [DOI] [PubMed] [Google Scholar]
  11. Franco E. L. Epidemiology of anogenital warts and cancer. Obstet Gynecol Clin North Am. 1996 Sep;23(3):597–623. [PubMed] [Google Scholar]
  12. Habel L. A., Van Den Eeden S. K., Sherman K. J., McKnight B., Stergachis A., Daling J. R. Risk factors for incident and recurrent condylomata acuminata among women. A population-based study. Sex Transm Dis. 1998 Jul;25(6):285–292. doi: 10.1097/00007435-199807000-00003. [DOI] [PubMed] [Google Scholar]
  13. Handley J., Lawther H., Horner T., Maw R., Dinsmore W. Ten year follow-up study of women presenting to a genitourinary medicine clinic with anogenital warts. Int J STD AIDS. 1992 Jan-Feb;3(1):28–32. doi: 10.1177/095646249200300107. [DOI] [PubMed] [Google Scholar]
  14. Hughes G., Simms I., Rogers P. A., Swan A. V., Catchpole M. New cases seen at genitourinary medicine clinics: England 1997. Commun Dis Rep CDR Suppl. 1998 Dec;8(7):S1–11. [PubMed] [Google Scholar]
  15. Jablonska S., Majewski S. Human papillomavirus infection in women. Special aspects of infectious diseases in women. Clin Dermatol. 1997 Jan-Feb;15(1):67–79. doi: 10.1016/s0738-081x(96)00111-3. [DOI] [PubMed] [Google Scholar]
  16. Jamison J. H., Kaplan D. W., Hamman R., Eagar R., Beach R., Douglas J. M., Jr Spectrum of genital human papillomavirus infection in a female adolescent population. Sex Transm Dis. 1995 Jul-Aug;22(4):236–243. doi: 10.1097/00007435-199507000-00007. [DOI] [PubMed] [Google Scholar]
  17. Koutsky L. A., Galloway D. A., Holmes K. K. Epidemiology of genital human papillomavirus infection. Epidemiol Rev. 1988;10:122–163. doi: 10.1093/oxfordjournals.epirev.a036020. [DOI] [PubMed] [Google Scholar]
  18. Langley P. C., Richwald G. A., Smith M. H. Modeling the impact of treatment options in genital warts: patient-applied versus physician-administered therapies. Clin Ther. 1999 Dec;21(12):2143–2155. doi: 10.1016/s0149-2918(00)87244-6. [DOI] [PubMed] [Google Scholar]
  19. Maw R. D., Reitano M., Roy M. An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS. 1998 Oct;9(10):571–578. doi: 10.1258/0956462981921143. [DOI] [PubMed] [Google Scholar]
  20. Minkoff H. L., Eisenberger-Matityahu D., Feldman J., Burk R., Clarke L. Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol. 1999 Apr;180(4):824–836. doi: 10.1016/s0002-9378(99)70653-8. [DOI] [PubMed] [Google Scholar]
  21. Munk C., Svare E. I., Poll P., Bock J. E., Kjaer S. K. History of genital warts in 10,838 women 20 to 29 years of age from the general population. Risk factors and association with Papanicolaou smear history. Sex Transm Dis. 1997 Nov;24(10):567–572. doi: 10.1097/00007435-199711000-00003. [DOI] [PubMed] [Google Scholar]
  22. Obalek S., Jablonska S., Favre M., Walczak L., Orth G. Condylomata acuminata in children: frequent association with human papillomaviruses responsible for cutaneous warts. J Am Acad Dermatol. 1990 Aug;23(2 Pt 1):205–213. doi: 10.1016/0190-9622(90)70200-2. [DOI] [PubMed] [Google Scholar]
  23. Pakarian F., Kaye J., Cason J., Kell B., Jewers R., Derias N. W., Raju K. S., Best J. M. Cancer associated human papillomaviruses: perinatal transmission and persistence. Br J Obstet Gynaecol. 1994 Jun;101(6):514–517. doi: 10.1111/j.1471-0528.1994.tb13153.x. [DOI] [PubMed] [Google Scholar]
  24. Petry K. U., Scheffel D., Bode U., Gabrysiak T., Köchel H., Kupsch E., Glaubitz M., Niesert S., Kühnle H., Schedel I. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer. 1994 Jun 15;57(6):836–840. doi: 10.1002/ijc.2910570612. [DOI] [PubMed] [Google Scholar]
  25. Simms I., Fairley C. K. Epidemiology of genital warts in England and Wales: 1971 to 1994. Genitourin Med. 1997 Oct;73(5):365–367. doi: 10.1136/sti.73.5.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Stone K. M. Human papillomavirus infection and genital warts: update on epidemiology and treatment. Clin Infect Dis. 1995 Apr;20 (Suppl 1):S91–S97. doi: 10.1093/clinids/20.supplement_1.s91. [DOI] [PubMed] [Google Scholar]
  27. Voog E., Löwhagen G. B. Follow-up of men with genital papilloma virus infection. Psychosexual aspects. Acta Derm Venereol. 1992;72(3):185–186. [PubMed] [Google Scholar]
  28. Walboomers J. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer J. A., Shah K. V., Snijders P. J., Peto J., Meijer C. J., Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 Sep;189(1):12–19. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES